메뉴 건너뛰기




Volumn 26, Issue 3, 2010, Pages 222-226

Drug-induced liver injury: A clinical update

Author keywords

Diagnosis; Drug induced liver injury; Hepatotoxicity; Natural history

Indexed keywords

ACETYLCYSTEINE; FIBRIC ACID DERIVATIVE; FLUCLOXACILLIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUKOCYTE ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; QUINOLONE DERIVATIVE; TELITHROMYCIN;

EID: 77951288290     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283383c7c     Document Type: Review
Times cited : (100)

References (27)
  • 2
    • 32644469104 scopus 로고    scopus 로고
    • Drug-related hepatotoxicity
    • Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med 2006; 354:731-739.
    • (2006) N Engl J Med , vol.354 , pp. 731-739
    • Navarro, V.J.1    Senior, J.R.2
  • 3
    • 57249086242 scopus 로고    scopus 로고
    • Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States
    • 34e1-4
    • Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135:1924-1934; 34e1-4
    • (2008) Gastroenterology , vol.135 , pp. 1924-1934
    • Chalasani, N.1    Fontana, R.J.2    Bonkovsky, H.L.3
  • 4
    • 18744376412 scopus 로고    scopus 로고
    • Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period
    • Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005; 129:512-521.
    • (2005) Gastroenterology , vol.129 , pp. 512-521
    • Andrade, R.J.1    Lucena, M.I.2    Fernandez, M.C.3
  • 5
    • 65449146368 scopus 로고    scopus 로고
    • Drug-induced liver injury in Japan: An analysis of 1676 cases between 1997 and 2006
    • Takikawa H, Murata Y, Horiike N, et al. Drug-induced liver injury in Japan: an analysis of 1676 cases between 1997 and 2006. Hepatol Res 2009; 39:427-431.
    • (2009) Hepatol Res , vol.39 , pp. 427-431
    • Takikawa, H.1    Murata, Y.2    Horiike, N.3
  • 7
    • 66449095257 scopus 로고    scopus 로고
    • Clinical characteristics of drug-induced liver injury in the elderly
    • Onji M, Fujioka S, Takeuchi Y, et al. Clinical characteristics of drug-induced liver injury in the elderly. Hepatol Res 2009; 39:546-552.
    • (2009) Hepatol Res , vol.39 , pp. 546-552
    • Onji, M.1    Fujioka, S.2    Takeuchi, Y.3
  • 8
    • 68949091980 scopus 로고    scopus 로고
    • Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex
    • Lucena MI, Andrade RJ, Kaplowitz N, et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology 2009; 49:2001-2009.
    • (2009) Hepatology , vol.49 , pp. 2001-2009
    • Lucena, M.I.1    Andrade, R.J.2    Kaplowitz, N.3
  • 9
    • 70449086055 scopus 로고    scopus 로고
    • The natural history of drug-induced liver injury
    • Bjornsson E. The natural history of drug-induced liver injury. Semin Liver Dis 2009; 29:357-363.
    • (2009) Semin Liver Dis , vol.29 , pp. 357-363
    • Bjornsson, E.1
  • 10
    • 70449103049 scopus 로고    scopus 로고
    • Genetic association studies in drug-induced liver injury
    • Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Semin Liver Dis 2009; 29:400-411.
    • (2009) Semin Liver Dis , vol.29 , pp. 400-411
    • Daly, A.K.1    Day, C.P.2
  • 11
    • 67649859295 scopus 로고    scopus 로고
    • HLA-B*57015701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
    • Daly AK, Donaldson PT, Bhatnagar P, et al. HLA-B*57015701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 2009; 41:816-819.
    • (2009) Nat Genet , vol.41 , pp. 816-819
    • Daly, A.K.1    Donaldson, P.T.2    Bhatnagar, P.3
  • 12
    • 0035088204 scopus 로고    scopus 로고
    • Drug-induced liver injury: Mechanisms and test systems
    • DOI 10.1053/jhep.2001.23505
    • Bissell DM, Gores GJ, Laskin DL, Hoofnagle JH. Drug-induced liver injury: mechanisms and test systems. Hepatology 2001; 33:1009-1013. (Pubitemid 32246655)
    • (2001) Hepatology , vol.33 , Issue.4 , pp. 1009-1013
    • Montgomery Bissell, D.1    Gores, G.J.2    Laskin, D.L.3    Hoofnagle, J.H.4
  • 13
    • 54449094314 scopus 로고    scopus 로고
    • Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury
    • Rochon J, Protiva P, Seeff LB, et al. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 2008; 48:1175-1183.
    • (2008) Hepatology , vol.48 , pp. 1175-1183
    • Rochon, J.1    Protiva, P.2    Seeff, L.B.3
  • 16
    • 33847081148 scopus 로고    scopus 로고
    • Idiosyncratic drug reactions: Current understanding
    • DOI 10.1146/annurev.pharmtox.47.120505.105150
    • Uetrecht J. Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 2007; 47:513-539. (Pubitemid 46272137)
    • (2007) Annual Review of Pharmacology and Toxicology , vol.47 , pp. 513-539
    • Uetrecht, J.1
  • 17
    • 46249118651 scopus 로고    scopus 로고
    • Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals
    • DOI 10.1002/hep.22272
    • Lammert C, Einarsson S, Saha C, et al. Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals. Hepatology 2008; 47:2003-2009. (Pubitemid 351945567)
    • (2008) Hepatology , vol.47 , Issue.6 , pp. 2003-2009
    • Lammert, C.1    Einarsson, S.2    Saha, C.3    Niklasson, A.4    Bjornsson, E.5    Chalasani, N.6
  • 18
    • 23044473682 scopus 로고    scopus 로고
    • Outcome and prognostic markers in severe drug-induced liver disease
    • DOI 10.1002/hep.20800
    • Bjornsson E, Olsson R. Outcome and prognostic markers in severe druginduced liver disease. Hepatology 2005; 42:481-489. (Pubitemid 41061102)
    • (2005) Hepatology , vol.42 , Issue.2 , pp. 481-489
    • Bjornsson, E.1    Olsson, R.2
  • 19
    • 4544363071 scopus 로고    scopus 로고
    • Liver transplantation for acute liver failure from drug induced liver injury in the United States
    • DOI 10.1002/lt.20204
    • Russo MW, Galanko JA, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 2004; 10:1018-1023. (Pubitemid 39232756)
    • (2004) Liver Transplantation , vol.10 , Issue.8 , pp. 1018-1023
    • Russo, M.W.1    Galanko, J.A.2    Shrestha, R.3    Fried, M.W.4    Watkins, P.5
  • 20
    • 75449112589 scopus 로고    scopus 로고
    • Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events
    • Lammert C, Bjornsson E, Niklasson A, Chalasani N. Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events. Hepatology 2010; 51:615-620.
    • (2010) Hepatology , vol.51 , pp. 615-620
    • Lammert, C.1    Bjornsson, E.2    Niklasson, A.3    Chalasani, N.4
  • 21
    • 67949100442 scopus 로고    scopus 로고
    • Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury
    • Suzuki A, Yuen N, Walsh J, et al. Co-medications that modulate liver injury and repair influence clinical outcome of acetaminophen-associated liver injury. Clin Gastroenterol Hepatol 2009; 7:882-888.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 882-888
    • Suzuki, A.1    Yuen, N.2    Walsh, J.3
  • 22
    • 0033045249 scopus 로고    scopus 로고
    • The natural history of histologically proved drug induced liver disease
    • Aithal PG, Day CP. The natural history of histologically proved drug induced liver disease. Gut 1999; 44:731-735.
    • (1999) Gut , vol.44 , pp. 731-735
    • Aithal, P.G.1    Day, C.P.2
  • 24
    • 59349097386 scopus 로고    scopus 로고
    • The long-term follow-up after idiosyncratic druginduced liver injury with jaundice
    • Bjornsson E, Davidsdottir L. The long-term follow-up after idiosyncratic druginduced liver injury with jaundice. J Hepatol 2009; 50:511-517.
    • (2009) J Hepatol , vol.50 , pp. 511-517
    • Bjornsson, E.1    Davidsdottir, L.2
  • 25
    • 58949090373 scopus 로고    scopus 로고
    • Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases
    • Brinker AD, Wassel RT, Lyndly J, et al. Telithromycin-associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases. Hepatology 2009; 49:250-257.
    • (2009) Hepatology , vol.49 , pp. 250-257
    • Brinker, A.D.1    Wassel, R.T.2    Lyndly, J.3
  • 27
    • 66149098373 scopus 로고    scopus 로고
    • Intravenous N-acetylcysteine improves transplant-free survival in early stage nonacetaminophen acute liver failure
    • 64e1
    • Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage nonacetaminophen acute liver failure. Gastroenterology 2009; 137:856-864; 64e1..
    • (2009) Gastroenterology , vol.137 , pp. 856-864
    • Lee, W.M.1    Hynan, L.S.2    Rossaro, L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.